Buchumschlag

Long‐term follow‐up of intradetrusor botulinum toxin utilisation: A comparison of patients with multiple sclerosis and idiopathic overactive bladder

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	William Chui, Joshua Kealey, Henry H. Yao, Garson Chan, Alvaro Bazo, Richard Parkinson, Helen E. O'Connell, Johan Gani
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2024
Schlagworte:	BJUI Compass
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

The use of intradetrusor botulinum toxin in the geriatric population
von: William Chui, et al.
Veröffentlicht: (2025)

Health utility value of overactive bladder in Japanese older adults
von: Takashi Yoshioka, et al.
Veröffentlicht: (2024)

Outcomes following intradetrusor onabotulinumtoxinA injections and sacral neuromodulation in older men
von: Leo D. Dreyfuss, et al.
Veröffentlicht: (2026)

Outcomes following intradetrusor onabotulinumtoxinA in a national cohort of nursing home residents
von: Leo D. Dreyfuss, et al.
Veröffentlicht: (2024)

Outcome of post‐prostatectomy stress urinary incontinence surgery in men with preoperative idiopathic detrusor overactivity
von: Nikita R. Bhatt, et al.
Veröffentlicht: (2024)

Understanding the long‐term impact of the COVID‐19 pandemic on non‐muscle‐invasive bladder cancer outcomes: 12‐Month follow‐up data from the international, prospective COVIDSurg Cancer study
von: Cameron E. Alexander, et al.
Veröffentlicht: (2024)

Reliability of mpMRI in diagnosing cancer prostate following intravesical BCG for bladder cancer
von: Arjun Pon Avudaiappan, et al.
Veröffentlicht: (2024)

Long‐term outcome of transurethral laser ablation for recurrent non‐muscle invasive bladder cancer: An EORTC risk‐matched study
von: Chase Peng Yun Ng, et al.
Veröffentlicht: (2025)

Urodynamics assessment in patients with multiple sclerosis
von: Nicholas Faure Walker, et al.
Veröffentlicht: (2026)

Early oncological outcomes of delayed radical prostatectomy: A prospective, international, follow‐up analysis of the COVIDSurg‐Cancer study
von: Arjun Nathan, et al.
Veröffentlicht: (2024)

Patient experience of bladder cancer: A data linkage study
von: Snehadhar Shah, et al.
Veröffentlicht: (2024)

Outcomes of Aquablation in BPH with bladder stones: Analysis of the ICARUS database
von: Joshua D. Cabral, et al.
Veröffentlicht: (2026)

Perioperative chemotherapy use and related outcomes in muscle‐invasive bladder cancer in Australia
von: Alison Hiong, et al.
Veröffentlicht: (2025)

Acu‐URO17 is a highly sensitive and specific bladder cancer biomarker
von: Liwu Guo, et al.
Veröffentlicht: (2024)

Comparison of staging MRI to re‐resection for localised bladder cancer: Narrative review
von: Hugo Klempfner, et al.
Veröffentlicht: (2024)

Haematuria cancer risk score as a predictor of muscle‐invasive bladder cancer
von: Serdar Turan, et al.
Veröffentlicht: (2025)

Predictors of adherence to surveillance cystoscopy for patients with non‐muscle invasive bladder cancer
von: Katherina Y. Chen, et al.
Veröffentlicht: (2026)

Understanding symptom contribution to sex inequality in bladder and renal cancer stage at diagnosis
von: Yin Zhou, et al.
Veröffentlicht: (2024)

Machine learning analysis for detecting late recurrence and loss to follow‐up after renal cell carcinoma surgery
von: Kodai Sato, et al.
Veröffentlicht: (2024)

Treatment preferences of patients with muscle invasive bladder cancer: A discrete choice experiment
von: Liam Mannion, et al.
Veröffentlicht: (2024)

Novel neoadjuvant therapies for muscle‐invasive bladder cancer: Systematic review and meta‐analysis
von: Shugo Yajima, et al.
Veröffentlicht: (2025)

Impact of pre‐stenting and bladder dranaige on intrapelvic pressure during retrograde intrarenal surgery
von: Sezgin Yeni, et al.
Veröffentlicht: (2025)

Preoperative FAN score predicts survival outcomes after radical cystectomy for bladder cancer
von: Yu Ishizuya, et al.
Veröffentlicht: (2026)

Reduced p63 expression is linked to unfavourable prognosis in muscle‐invasive urothelial carcinoma of the bladder
von: Kira Furlano, et al.
Veröffentlicht: (2024)

Germline homologous recombination repair (gHRR) variants in bladder cancer: Preliminary evidence and clinical implications
von: Rodolfo Hurle, et al.
Veröffentlicht: (2025)

Lymph node dissection during cystectomy for non‐muscle‐invasive bladder cancer: A systematic review
von: Sean Lim, et al.
Veröffentlicht: (2026)

The potential role of precision medicine to alleviate racial disparities in prostate, bladder and renal urological cancer care
von: Kunal K. Sindhu, et al.
Veröffentlicht: (2024)

Metabolic abnormalities in pure vs. mixed struvite stone formers: A retrospective comparative analysis utilising large language models for data extraction
von: Juanita Velasquez Ospina, et al.
Veröffentlicht: (2025)

Time toxicity of intravesical BCG versus sequential intravesical gemcitabine and docetaxel for non‐muscle‐invasive bladder cancer
von: Jacob Hanna, et al.
Veröffentlicht: (2026)

Long non‐coding RNAs define favourable biology in high‐risk non‐muscle‐invasive bladder cancer
von: Rachel Weng, et al.
Veröffentlicht: (2025)

Comparing fluorodeoxyglucose positron emission tomography with computed tomography in staging for nodal and distant metastasis in urothelial/bladder cancer
von: Mohammed Al‐Zubaidi, et al.
Veröffentlicht: (2024)

Understanding oncological and sexual function outcomes with gynaecological organ preserving cystectomy in women with bladder cancer; a systematic review
von: Rebecca Martin, et al.
Veröffentlicht: (2025)

A systematic review of the patient reported outcomes that affect patients with muscle invasive bladder cancer after radical cystectomy and urinary diversion
von: John Lahoud, et al.
Veröffentlicht: (2024)

Real‐world use of maintenance bacillus Calmette‐Guérin therapy in patients with non‐muscle‐invasive bladder cancer in Japan: ASUKA study
von: Makito Miyake, et al.
Veröffentlicht: (2025)

Real‐world oncological and toxicity outcomes with the Moscow strain of intravesical BCG for non‐muscle invasive bladder cancer—Implications for global shortage
von: Amandeep Arora, et al.
Veröffentlicht: (2025)

Does bladder outflow obstruction obfuscate the traditional clinical factors that are used to assess the risk of prostate cancer at rapid‐access diagnostic clinics?
von: Thomas Philip Cahill, et al.
Veröffentlicht: (2024)

Intravesical gemcitabine and docetaxel vs. re‐induction Bacillus Calmette Guerin as first‐line salvage therapy for non‐muscle invasive bladder cancer
von: Kylie Yen‐Yi Lim, et al.
Veröffentlicht: (2025)

The effect of negative, single and multi‐organism positive cultures on outcomes following PCNL
von: Katya Hanessian, et al.
Veröffentlicht: (2026)

Recurrence patterns following nephrectomy for renal cell carcinoma in a Danish nationwide cohort
von: Goran Bencina, et al.
Veröffentlicht: (2024)

MRI performance to identify clinically significant prostate cancer following focal cryo‐ablation
von: Herbert Lepor, et al.
Veröffentlicht: (2025)